RIGL Market Cap & Key Metrics
Rigel Pharmaceuticals, Inc.
$48.72
+$0.73(+1.52%)
73
Overall
80
Value
75
Tech
65
Quality
Market Cap
$910.08M
Volume
216.65K
52W Range
$24.95 - $52.24
Target Price
$63.00
RIGL market cap is $910.08M. This page lists Rigel Pharmaceuticals, Inc.'s P/E ratio, EPS estimates, dividend yield, payout ratio and MarketXLS scores.
RIGL Key Metrics
- Market cap
- $910.08M
- P/E ratio (current-year EPS estimate)
- 16.35
- EPS estimate, current year
- $2.98
- EPS growth, 3-year
- +100.00%
- Value score
- 80
- Quality score
- 65
- Technical score
- 75
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $294.28M | $179.28M | $116.88M | $120.24M | $149.24M |
| EBITDA | $131.56M | $28.51M | -$16.98M | -$53.87M | -$11.29M |
| EPS | $20.40 | $0.99 | $-1.40 | $-3.40 | $-0.11 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | RIGL | $48.72 | +1.5% | 216.65K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Rigel Pharmaceuticals, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW